The expression and localisation of fl-nerve growth factor (f,-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation
1996

Beta-Nerve Growth Factor in Prostate Tissue

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): AB Paul, ES Grant, FK Habib

Primary Institution: University Department of Surgery/Urology, Western General Hospital

Hypothesis

The study examines the expression and localization of beta-nerve growth factor (β-NGF) in benign and malignant human prostate tissue and its relationship to neuroendocrine differentiation.

Conclusion

The study found that β-NGF is localized to prostate epithelium, with no significant difference in concentrations between malignant and benign tissues.

Supporting Evidence

  • β-NGF concentrations were not significantly different in malignant than in benign tissues.
  • The presence of β-NGF mRNA transcripts was confirmed by RT-PCR.
  • Western blot analysis showed a protein co-migrating with recombinant human β-NGF.

Takeaway

This study looked at a substance called beta-nerve growth factor in prostate tissue to see if it was different in healthy and cancerous samples, but it turned out to be similar in both.

Methodology

The study used reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry, and ELISA to analyze prostate tissue samples.

Limitations

The study was limited by the inability to correlate β-NGF concentrations to neuroendocrine differentiation in malignant tissues.

Participant Demographics

15 benign prostatic hyperplastic and 15 prostate cancer patients.

Statistical Information

P-Value

0.512

Statistical Significance

p=0.512

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication